We are live on
!
Find out more
RG
Renaissance Group Portfolio holdings
AUM
$2.39B
1-Year Est. Return
27.81%
This Fund
S&P 500
This Quarter
Est. Return
+7.32%
1 Year Est. Return
+27.81%
3 Year Est. Return
+92.11%
5 Year Est. Return
+135.4%
10 Year Est. Return
+451.85%
AUM
$2.43B
AUM Growth
-$134M
(-5.2%)
Cap. Flow
-$248M
Cap. Flow
% of AUM
-10.2%
Top 10 Holdings %
Top 10 Hldgs %
17.32%
Holding
302
New
25
Increased
58
Reduced
131
Closed
62
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Arista Networks
ANET
|
+$32.4M |
| 2 |
Tradeweb Markets
TW
|
+$32M |
| 3 |
KKR & Co
KKR
|
+$31.7M |
| 4 |
Applovin
APP
|
+$28.1M |
| 5 |
Neurocrine Biosciences
NBIX
|
+$28M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$33.7M |
| 2 |
Everest Group
EG
|
+$30.9M |
| 3 |
Target
TGT
|
+$30M |
| 4 |
Illinois Tool Works
ITW
|
+$29.5M |
| 5 |
Lincoln Electric
LECO
|
+$26.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.13% |
| 2 | Healthcare | 13.65% |
| 3 | Consumer Discretionary | 11.83% |
| 4 | Financials | 11.41% |
| 5 | Industrials | 10.88% |
Similar funds
MAS
DSCM
CWM
HAG
CIP
RAM
BJL
PA
Renaissance Group's Q3 2024 Portfolio in Review
As of Q3 2024, Renaissance Group held 302 positions worth $2.43B, down 5.2% from $2.56B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Renaissance Group withdrew a net $248M in Q3 2024, closing 62 positions and reducing 131 holdings. Its most notable exit was Target, an estimated $30M position sold in full.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Renaissance Group opened a new position in Arista Networks worth $35.7M.
- Renaissance Group's largest Q3 2024 buy was Arista Networks: 372,260 shares worth $35.7M.
- Renaissance Group added most to Millicom in Q3 2024, an estimated $6.17M increase.
- Renaissance Group's biggest Q3 2024 reduction was Vertex Pharmaceuticals, cutting an estimated $33.7M.
- Renaissance Group fully exited Target in Q3 2024, selling an estimated $30M.
- Renaissance Group's ten largest holdings make up 17% of its $2.43B portfolio in Q3 2024.
- Renaissance Group opened 25 new positions and closed 62 in Q3 2024.
- Renaissance Group's portfolio value fell 5.2% quarter-over-quarter to $2.43B.
Based on Renaissance Group's 13F filing for Q3 2024, filed 12 Nov 2024.